HQ Sustainable Maritime Industries, Inc.: $5 Million Financing for Aquaculture as Practiced by HQ
13th Nov 2006, 23:03 GMT
SEATTLE, WA (MARKET WIRE) HQ Sustainable Maritime Industries, Inc. (HQ) (OTCBB: HQSM), a leader in zero-toxin integrated aquaculture and aquatic product processing, announced today that it has completed a $5 million convertible promissory notes financing with two investors. Attached to the financing is the right to purchase an aggregate of up to 4 million shares of Common Stock.
HQ Sustainable Maritime Industries, Inc.: $5 Million Financing for Aquaculture as Practiced by HQ related news:
- $5 Million Financing for Aquaculture as Practiced by HQ — ArriveNet : Press Releases
- HQ Sustainable Maritime Industries, Inc: HQ Quarter Revenues Up 24%; Nine Month Revenues Up 50% — Market Wire - Transportation and Logistics
- HQ Quarter Revenues Up 24%; Nine Month Revenues Up 50% — ArriveNet : Press Releases
- NOAA 10-year Aquaculture Plan Available for Public Comment — NOAA Home Page
- Giant Industries' buyer slashes price by $100 million — azcentral.com | business
- Giant Industries reports $3 per share net income in Q3 — bizjournals.com Energy:Oil & Gas headlines
- Pulte pulls out of Extreme Networks HQ purchase — bizjournals.com Business Services:Accounting & Consulting headlines
- Pulte pulls out Extreme Networks HQ purchase — bizjournals.com Business Services:Accounting & Consulting headlines
- Dios Exploration Inc.: Financing With Mavrix — ArriveNet : Press Releases
- Bell Industries to buy Verizon's SkyTel, reports 3Q loss — bizjournals.com Banking & Financial Services:Commercial Banking headlines
Latest news from Market Wire - Medical and Healthcare:
- slp3D: ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Precise Biometrics AB: Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Lenstec, Inc.: Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL
- Takeda Pharmaceuticals North America: New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of Atherosclerosis as Indicated by CIMT in Patients With Type 2 Diabetes
- Dairy Fresh Farms Inc.: Dairy Fresh Farms Announces It Has Signed a Licensing Deal With NutriOne for the Canadian Market
- OTSP: Study to Be Published in JAMA: Diabetes Drug ACTOS(R) (pioglitazone HCl) Halted Progression of Key Marker for Atherosclerosis; Improvements Indicated by Carotid Intima-Media Thickness (CIMT)
- Vue Technology: Vue Technology Introduces First UHF Solution for Item-Level Visibility in the Retail Pharmacy; New RFID Solution Tracks Liquids, Pill Bottles, Blister Packs and Gels
- Union Dental Holdings, Inc.: Union Dental Signs Contract to Provide Dental Network for United Association of Plumbers and Pipefitters
- MEDSEEK: MEDSEEK, SelfCareNet, & Primetime Medical Partner to Deliver Integrated Consumer-Centric Solution
- Ridgecrest Healthcare Group, Inc.: Ridgecrest Healthcare Group to Acquire NOBO List